Therapeutic designed poly (lactic-co-glycolic acid) cylindrical oseltamivir phosphate-loaded implants impede tumor neovascularization, growth and metastasis in mouse model of human pancreatic carcinoma

References

• FolkmanJFundamental concepts of the angiogenic processCurr Mol Med20033764365114601638
   PubMed Web of Science ®Google Scholar
• SegalESatchi-FainaroRDesign and development of polymer conjugates as anti-angiogenic agentsAdv Drug Deliv Rev200961131159117619699248
   PubMed Web of Science ®Google Scholar
• KerbelRSKamenBAThe anti-angiogenic basis of metronomic chemotherapyNat Rev Cancer20044642343615170445
   PubMed Web of Science ®Google Scholar
• PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
   PubMed Web of Science ®Google Scholar
• DavisMEChenZGShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNat Rev Drug Discov20087977178218758474
   PubMed Web of Science ®Google Scholar
• SuriSSFenniriHSinghBNanotechnology-based drug delivery systemsJ Occup Med Toxicol200721618053152
   PubMedGoogle Scholar
• NoguchiYWuJDuncanREarly phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissuesJpn J Cancer Res19988933073149600125
   PubMedGoogle Scholar
• HaxhoFAllisonSAlghamdiFOseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinomaBreast Cancer Targets Ther20146191203
   PubMedGoogle Scholar
• GilmourAMAbdulkhalekSChengTSA novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancerCell Signal201325122587260323993964
   PubMed Web of Science ®Google Scholar
• AbdulkhalekSHrynykMSzewczukMRA novel G-protein-coupled receptor-signaling platform and its targeted translation in human diseaseRes Rep Biochem201331730
   Google Scholar
• XiongHQAbbruzzeseJLEpidermal growth factor receptor-targeted therapy for pancreatic cancerSemin Oncol2002295 Suppl 14313712422311
   PubMed Web of Science ®Google Scholar
• SafranHDipetrilloTIannittiDGemcitabine, paclitaxel, and radiation for locally advanced pancreatic cancer: a Phase I trialInt J Radiat Oncol Biol Phys200254113714112182983
   PubMed Web of Science ®Google Scholar
• SafranHRathoreRPaclitaxel as a radiation sensitizer for locally advanced pancreatic cancerCrit Rev Oncol Hematol2002431576212098607
   PubMed Web of Science ®Google Scholar
• DesaiKGMallerySRSchwendemanSPEffect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implantsEur J Pharm Biopharm200870118719818472254
   PubMed Web of Science ®Google Scholar
• O’SheaLKAbdulkhalekSAllisonSNeufeldRJSzewczukMRTherapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu(R)) disables cancer cell survival in human pancreatic cancer with acquired chemoresistanceOnco Targets Ther2014711713424470763
   PubMed Web of Science ®Google Scholar
• GreenMDNetteyHWirtzRADetermination of oseltamivir quality by colorimetric and liquid chromatographic methodsEmerg Infect Dis200814455255618394271
   PubMed Web of Science ®Google Scholar
• DegimITCelebiNControlled delivery of peptides and proteinsCurr Pharm Des20071319911717266590
   PubMed Web of Science ®Google Scholar
• ChaubulMPolylactides/glycolides – excipients for injectable drug delivery and beyondDrug Deliv Technol200223436
   Google Scholar
• LuJMWangXMarin-MullerCCurrent advances in research and clinical applications of PLGA-based nanotechnologyExpert Rev Mol Diagn20099432534119435455
   PubMed Web of Science ®Google Scholar
• KreyeFSiepmannFSiepmannJDrug release mechanisms of compressed lipid implantsInt J Pharm20114041–2273521055453
   PubMed Web of Science ®Google Scholar
• AnsaryRHAwangMBRahmanMMBiodegradable poly(D,L-lactic-co-glycolic acid)-based micro/nanoparticles for sustained release of protein drugs – a reviewTrop J Pharm Res201413711791190
   Web of Science ®Google Scholar
• ArnoldWSennPHennigMNovel slow- and fast-type drug release round-window microimplants for local drug application to the cochlea: an experimental study in guinea pigsAudiol Neurootol2005101536315591792
   PubMed Web of Science ®Google Scholar
• HouJLiCChengLGuoSZhangYTangTStudy on hydrophilic 5-fluorouracil release from hydrophobic poly(epsilon-caprolactone) cylindrical implantsDrug Dev Ind Pharm20113791068107521449700
   PubMed Web of Science ®Google Scholar
• HiremathJPatelBAithaRKMuraPPalavalliGSCharacterization of cylindrical and strip-shaped tamoxifen citrate-loaded biodegradable implantsAsian J Pharm20115209214
   Google Scholar
• HiremathJGDeviVKPaclitaxel loaded biodegradable poly(sebacic acid-co-ricinoleic acid) cylindrical implants for local delivery – in vitro characterizationAsian J Pharm20137125132
   Google Scholar
• DanhierFAnsorenaESilvaJMCocoRLe BretonAPreatVPLGA-based nanoparticles: an overview of biomedical applicationsJ Control Release2012161250552222353619
   PubMed Web of Science ®Google Scholar
• CarlinDJNanotoxicology and nanotechnology: new findings from the NIEHS and Superfund Research Program scientific communityRev Environ Health2014291–210510724695034
   PubMedGoogle Scholar
• HrynykMMartins-GreenMBarronAENeufeldRJAlginate-PEG sponge architecture and role in the design of insulin release dressingsBiomacromolecules20121351478148522506765
   PubMed Web of Science ®Google Scholar
• HrynykMMartins-GreenMBarronAENeufeldRJSustained prolonged topical delivery of bioactive human insulin for potential treatment of cutaneous woundsInt J Pharm20103981–214615420691251
   PubMedGoogle Scholar
• AhmedARBodmeierRPreparation of preformed porous PLGA microparticles and antisense oligonucleotides loadingEur J Pharm Biopharm200971226427018840521
   PubMed Web of Science ®Google Scholar
• MooneyDJBreuerCMcNamaraKVacantiJPLangerRFabricating tubular devices from polymers of lactic and glycolic acid for tissue engineeringTissue Eng19951210711819877920
   PubMedGoogle Scholar
• OhHHLuHKawazoeNChenGMicropatterned angiogenesis induced by poly(d,l-lactic-co-glycolic acid) mesh-structured scaffoldsJ Bioact Compat Polym201227297106
   Web of Science ®Google Scholar
• PanZDingJPoly(lactide-co-glycolide) porous scaffolds for tissue engineering and regenerative medicineInterface Focus20122336637723741612
   PubMed Web of Science ®Google Scholar
• ChangGCiTYuLDingJEnhancement of the fraction of the active form of an antitumor drug topotecan via an injectable hydrogelJ Control Release20111561212721777632
   PubMed Web of Science ®Google Scholar
• RongXYuanWLuYMoXSafety evaluation of poly(lactic-co-glycolic acid)/poly(lactic-acid) microspheres through intravitreal injection in rabbitsInt J Nanomed2014930573068
   PubMed Web of Science ®Google Scholar
• DhupSDadhichRKPorporatoPESonveauxPMultiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasisCurr Pharm Des201218101319133022360558
   PubMed Web of Science ®Google Scholar
• HongJTKimEJAhnKSInhibitory effect of glycolic acid on ultraviolet-induced skin tumorigenesis in SKH-1 hairless mice and its mechanism of actionMol Carcinog200131315216011479924
   PubMed Web of Science ®Google Scholar
• AbdulkhalekSGeenOBrodhagenLTranscriptional factor Snail controls tumor neovascularization, growth and metastasis in mouse model of human ovarian carcinomaClin Transl Med2014328
   Google Scholar
• ShahaniKPanyamJHighly loaded, sustained-release microparticles of curcumin for chemopreventionJ Pharm Sci201110072599260921547911
   PubMed Web of Science ®Google Scholar
• ShahaniKSwaminathanSKFreemanDBlumAMaLPanyamJInjectable sustained release microparticles of curcumin: a new concept for cancer chemopreventionCancer Res201070114443445220460537
   PubMed Web of Science ®Google Scholar